| Novation Inks Deal for HIV Antibody Test |
|
|
|
| HIV AIDS - HIV and Aids News | |||||||
| Written by The Associated Press | |||||||
| Thursday, 20 April 2006 | |||||||
|
BETHLEHEM, Pa. — Health care contracting services company Novation, a unit of VHA Inc., on Wednesday signed a deal with Abbott Laboratories to make OraSure Technologies Inc.'s rapid HIV antibody test available throughout its healthcare network.
The Oraquick Advance Rapid HIV 1/2 antibody test can quickly test for antibodies to both HIV-1 and HIV-2. It has received Food and Drug Administration approval for use on oral fluid, finger stick or venipuncture whole blood and plasma specimens. Abbott is the exclusive distributor of the product in the United States. The single-source new technology agreement should expand the test's use in certain hospitals, OraSure President and Chief Executive Douglas A. Michels said in a prepared statement. Abbott's contract with Novation began on April 1 and will run through March 31, 2009. Shares of OraSure added 14 cents to $10.45 in morning trading on the Nasdaq. Abbott Laboratories shares fell 40 cents to $41.28 on the New York Stock Exchange. | |||||||
|
|||||||
| Last Updated ( Thursday, 20 April 2006 ) | |||||||
| < Prev | Next > |
|---|